BSE filing, NSE: ALKEM. Summary written from the filing by ALFA Finder's alert engine.
Alkem Laboratories Ltd: key numbers
- Share price
- ₹5,236.00
- Market cap
- ₹62,604 Cr
- Revenue (annual)
- ₹14,712 Cr
- Net profit (annual)
- ₹2,302 Cr
- P/E (TTM)
- 29.0×Sector 41.3×
- Promoter holding
- 49.70%+0.00% QoQ
- FII holding
- 10.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alkem Laboratories Ltd
All →Alkem Laboratories Management Change
Alkem Laboratories appointed Dr. Amrut Naik as CEO effective November 11, 2026. The Board designated him as Key Managerial Personnel at its November 3 meeting.
Alkem Laboratories Business Update
Alkem informed the exchange that US FDA completed inspection of its Mandva API facility with no Form 483 observations. The clean result confirms regulatory compliance.
Alkem Laboratories Legal & Regulatory
Alkem Laboratories has initiated a forensic audit by Grant Thornton Bharat LLP following alleged misappropriation of funds by a former employee.
Alkem Laboratories Other Announcement
Alkem Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements. This document details the company's equity structure.
Alkem Laboratories Management Change
Alkem Laboratories appointed Laxmikant Tiwari and Nilesh Vartak as Senior Management Personnel effective 12 October 2026. The appointments strengthen pharmaceutical operations and supply chain leadership.
Alkem Laboratories Management Change
Alkem Laboratories CFO Nitin Agrawal resigned effective 30 September 2026 for new opportunities. He was also a Key Managerial Personnel of the company.
Other board meeting date announcements
All →Orient Beverages Board Meeting Date
Orient Beverages Limited will hold a board meeting on 13 Nov 2026 to consider unaudited quarterly standalone and consolidated results for September 2026. Trading window closes 15 Nov 2026.
Shukra Jewellery Board Meeting Date
Shukra Jewellery intimated that its board is scheduled for 14 November 2026. It will consider and approve the unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026.
Megatherm Induction Board Meeting Date
Megatherm Induction Intimated a board meeting scheduled for 12-Nov-2026 to approve unaudited half-yearly results. This is a prior intimation; no results or decisions are announced.
Sri Havisha Hospitality and Infrastructure Board Meeting Date
Sri Havisha Hospitality has scheduled a board meeting on 12 November 2026 to consider unaudited standalone half-yearly results and other business. The trading window closes from 1 October 2026 to 14 November 2026.
Kanoria Chemicals & Industries Board Meeting Date
Kanoria Chemicals & Industries gave advance notice that its Board will meet on 13 November 2026. Inter alia, it will consider approval of unaudited financial results for the September 2026 quarter and half year.
Complete Sports and Management India Board Meeting Date
Complete Sports and Management India Ltd intimated BSE that its board will meet on 12 Nov 2026 to approve H1 FY27 unaudited results. No financial figures are disclosed in this advance notice.